Gene · 7439
Papers1,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ANATOMICAL AND FUNCTIONAL OUTCOMES OF BEVACIZUMAB TREATMENT IN PEDIATRIC AUTOSOMAL RECESSIVE BESTROPHINOPATHY. | Retin Cases Brief Rep | 2024 | 36729806 | PubTator, text mining | PubMed |
| CHOROIDAL NEVUS ASSOCIATED WITH VITELLIFORM DEPOSITION IN A PATIENT WITH AUTOSOMAL DOMINANT BEST DYSTROPHY. | Retin Cases Brief Rep | 2024 | 36240079 | PubTator, text mining | PubMed |
| AAV for Gene Therapy in Ocular Diseases: Progress and Prospects. | Research (Wash D C) | 2023 | 38188726 | PubTator, text mining | PubMed |
| Inherited retinal diseases and gene therapy update. | Saudi J Ophthalmol | 2023 | 38155682 | PubTator, text mining | PubMed |
| Gene therapy in bestrophinopathies: Insights from preclinical studies in preparation for clinical trials. | Saudi J Ophthalmol | 2023 | 38155675 | PubTator, text mining | PubMed |
| Recent Advances in Imaging Macular Atrophy for Late-Stage Age-Related Macular Degeneration. | Diagnostics (Basel) | 2023 | 38132220 | PubTator, text mining | PubMed |
| Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration. | Cells | 2023 | 38067097 | PubTator, text mining | PubMed |
| Diagnostic Challenges in ABCA4-Associated Retinal Degeneration: One Gene, Many Phenotypes. | Diagnostics (Basel) | 2023 | 38066771 | PubTator, text mining | PubMed |
| Pathologic vs. protective roles of hypoxia-inducible factor 1 in RPE and photoreceptors in wet vs. dry age-related macular degeneration. | Proc Natl Acad Sci U S A | 2023 | 38055741 | PubTator, text mining | PubMed |
| Retinitis Pigmentosa: Pathogenesis, Diagnostic Findings, and Treatment. | Cureus | 2023 | 38034182 | PubTator, text mining | PubMed |
| Machine learning for pan-cancer classification based on RNA sequencing data. | Front Mol Biosci | 2023 | 38028533 | PubTator, text mining | PubMed |
| Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases. | Stem Cell Res Ther | 2023 | 38012786 | PubTator, text mining | PubMed |
| A Molecular Genetic Analysis of RPE65-Associated Forms of Inherited Retinal Degenerations in the Russian Federation. | Genes (Basel) | 2023 | 38002999 | PubTator, text mining | PubMed |
| Recent Advances of Adipose-Tissue-Derived Mesenchymal Stem Cell-Based Therapy for Retinal Diseases. | J Clin Med | 2023 | 38002628 | PubTator, text mining | PubMed |
| Paraoxonase 2 Deficiency Causes Mitochondrial Dysfunction in Retinal Pigment Epithelial Cells and Retinal Degeneration in Mice. | Antioxidants (Basel) | 2023 | 37891899 | PubTator, text mining | PubMed |
| Astrocytes in human central nervous system diseases: a frontier for new therapies. | Signal Transduct Target Ther | 2023 | 37828019 | PubTator, text mining | PubMed |
| End binding-3 inhibitor activates regenerative program in age-related macular degeneration. | Cell Rep Med | 2023 | 37794584 | PubTator, text mining | PubMed |
| Polygenic Risk Score and Rare Variant Burden Identified by Targeted Sequencing in a Group of Patients with Pigment Epithelial Detachment in Age-Related Macular Degeneration. | Genes (Basel) | 2023 | 37761846 | PubTator, text mining | PubMed |
| MULTIZONAL OUTER RETINOPATHY AND RETINAL PIGMENT EPITHELIOPATHY (MORR): A Newly Recognized Entity or an Unusual Variant of AZOOR? | Retina | 2023 | 37748093 | PubTator, text mining | PubMed |
| Comprehensive Genetic Analysis Unraveled the Missing Heritability and a Founder Variant of BEST1 in a Chinese Cohort With Autosomal Recessive Bestrophinopathy. | Invest Ophthalmol Vis Sci | 2023 | 37747403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7439/papers?page=7